 NEW YORK, Feb. 22, 2022 GLOBE NEWSWIRE -- Intra-Cellular Therapies, Inc. Nasdaq: ITCI, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system CNS disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, March 1, 2022, to provide a corporate update and discuss details of the Companys financial results for the quarter and year ended December 31, 2021. 